Scientists headed by a team at the University of Tokyo have identified a protein, known as podoplanin (PDPN), that is common to both human and canine mucosal melanoma, and which appears to mobilize ...

Although rare, mucosal melanoma in humans has a low survival rate. It has been difficult to investigate due to a lack of similar cancers in animals for study. Researchers explored a protein common to ...

Although rare, mucosal melanoma in humans has a low survival rate. It has been difficult to investigate due to a lack of similar cancers in animals for study. Researchers explored a protein common to ...

A phase 2 study evaluated meaningful activity from lifileucel for patients with advanced mucosal melanoma who experienced disease progression on immune checkpoint inhibitors. Lifileucel led to ...

J.B. Ward's experience highlights the importance of self-advocacy in managing rare cancers, emphasizing the need for patients to seek multiple opinions and question medical advice. Mucosal melanoma is ...

Is one year enough? Extended adjuvant dabrafenib plus trametinib for Chinese patients with resected stage III melanoma. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This ...

The Melanoma Research Alliance launched a national biorepository at the University of Colorado to collect melanoma samples, focusing on rare subtypes for diagnostic and treatment research.

In this study, researchers explored disparities in metastatic cutaneous melanoma survival following the introduction of immunotherapies.